Molecular genetic analysis of ABO blood group variations reveals 29 novel ABO subgroup alleles

Transfusion

Volumn 53, Issue 11 PART 2, 2013, Pages 2910-2916

  Cai, Xiaohong ^a   Jin, Sha ^b   Liu, Xi ^b   Fan, Liangfeng ^b   Lu, Qiong ^b   Wang, Jianlian ^b   Shen, Wei ^b   Gong, Songsong ^b   Qiu, Li ^b   Xiang, Dong ^a  

^a Shanghai Blood Center   (China)

^b Tanggu Blood Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BLOOD GROUP ABO SYSTEM; CODON; DNA SEQUENCE; EXON; GENE DELETION; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; MOLECULAR CLONING; MOLECULAR GENETICS; POINT MUTATION; SEROLOGY; BLOOD DONOR; CLASSIFICATION; GENE FREQUENCY; GENETIC TRANSFECTION; GENETICS; GENOTYPE; IMMUNOLOGY; K562 CELL LINE; PHENOTYPE; PHYSIOLOGY; PROMOTER REGION; CELL STRAIN K 562;

BLOOD GROUP ABO SYSTEM;

ABO BLOOD-GROUP SYSTEM; ALLELES; BLOOD DONORS; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HUMANS; K562 CELLS; PHENOTYPE; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; SEROLOGIC TESTS; TRANSFECTION;

EID: 84893155543     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12168     Document Type: Article

References (27)

1. Yamamoto F, Clausen H, White T, Marken J, Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature 1990;345: 229-33.
2. Yamamoto F, McNeill PD, Hakomori S. Genomic organization of human histo-blood group ABO genes. Glycobiology 1995;5: 51-8.
3. Hata Y, Kominato Y, Yamamoto FI, Takizawa H. Characterization of the human ABO gene promoter in erythroid cell lineage. Vox Sang 2002;82: 39-46.
4. Kominato Y, Tsuchiya T, Hata N, Takizawa H, Yamamoto F. Transcription of human ABO histo-blood group genes is dependent upon binding of transcription factor CBF/NF-Y to minisatellite sequence. J Biol Chem 1997;272: 25890-8.
5. Yu LC, Chang CY, Twu YC, Lin M. Human histo-blood group ABO glycosyltransferase genes: different enhancer structures with different transcriptional activities. Biochem Biophys Res Commun 2000;273: 459-66.
6. Seltsam A, Wagner FF, Gruger D, Gupta CD, Bade-Doeding C, Blasczyk R. Weak blood group B phenotypes may be caused by variations in the CCAAT-binding factor/NF-Y enhancer region of the ABO gene. Transfusion 2007;47: 2330-5.
7. Thuresson B, Chester MA, Storry JR, Olsson ML. ABO transcript levels in peripheral blood and erythropoietic culture show different allele-related patterns independent of the CBF/NF-Y enhancer motif and multiple novel allelespecific variations in the 5?- and 3?-noncoding regions. Transfusion 2008;48: 493-504.
8. Okiura T, Nishimukai H, Nishimura K, Orimoto C, Fukumori Y. DNA polymorphisms and haplotypes in the 5?-upstream region of the ABO blood group gene. Leg Med (Tokyo) 2006;8: 121-7.
9. Yan L, Zhu F, Liu Y, Xu X, Hong X. Sequences variations in 5?-flanking region of ABO gene and correlation with ABO alleles in the indigenous Chinese. Vox Sang 2008;94: 227-33.
10. Xiang D, Liu X, Guo ZH, Zhou XY, Zhang JM, Shen W. Study on ABO subgroup in Chinese population in Shanghai area. Chin J Blood Transfus 2006;19: 25-6. In Chinese.
11. Roback J. AABB technical manual. 16th ed. Bethesda (MD): American Association of Blood Banks; 2008.
12. Daniels G. Human blood groups. 2nd ed. Oxford: Blackwell Scientific; 2002. p. 25-58.
13. Cai XH, Jin S, Liu X, Shen W, Lu Q, Wang JL, Fan LF, Sun JL, Liu DZ, Xiang D. Molecular genetic analysis for the B subgroup revealing two novel alleles in the ABO gene. Transfusion 2008;48: 2442-7.
14. Chen YJ, Chen PS, Liu HM, Lyou JY, Hu HY, Lin JS, Tzeng CH. Novel polymorphisms in exons 6 and 7 of A/B alleles detected by polymerase chain reaction-single strand conformation polymorphism. Vox Sang 2006;90: 119-27.
15. Hosseini-Maaf B, Letts JA, Persson M, Smart E, LePennec PY, Hustinx H, Zhao Z, Palcic MM, Evans SV, Chester MA, Olsson ML. Structural basis for red cell phenotypic changes in newly identified, naturally occurring subgroup mutants of the human blood group B glycosyltransferase. Transfusion 2007;47: 864-75.
16. Ogasawara K, Bannai M, Saitou N, Yabe R, Nakata K, Takenaka M, Fujisawa K, Uchikawa M, Ishikawa Y, Juji T, Tokunaga K. Extensive polymorphism of ABO blood group gene: three major lineages of the alleles for the common ABO phenotypes. Hum Genet 1996;97: 777-83.
17. Gastinel LN, Bignon C, Misra AK, Hindsgaul O, Shaper JH, Joziasse DH. Bovine alpha1,3-galactosyltransferase catalytic domain structure and its relationship with ABO histo-blood group and glycosphingolipid glycosyltransferases. EMBO J 2001;20: 638-49.
18. Gasperikova D, Tribble ND, Stanik J, Huckova M, Misovicova N, van de Bunt M, Valentinova L, Barrow BA, Barak L, Dobransky R, Bereczkova E, Michalek J, Wicks K, Colclough K, Knight JC, Ellard S, Klimes I, Gloyn AL. Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G?C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans. Diabetes 2009;58: 1929-35.
19. Andreoli V, Trecroci F, La Russa A, Cittadella R, Liguori M, Spadafora P, Caracciolo M, Di Palma G, Colica C, Gambardella A, Quattrone A. Presenilin enhancer-2 gene: identification of a novel promoter mutation in a patient with early-onset familial Alzheimer's disease. Alzheimers Dement 2011;7: 574-8.
20. Combes P, Kammoun N, Monnier A, Gonthier-Gueret C, Giraud G, Bertini E, Chahnez T, Fakhfakh F, Boespflug-Tanguy O, Vaurs-Barriere C. Relevance of GJC2 promoter mutation in Pelizaeus-Merzbacher-like disease. Ann Neurol 2012;71: 146-8.
21. Wilkinson MF, Shyu AB. RNA surveillance by nuclear scanning? Nat Cell Biol 2002;4:E144-7.
22. Hata Y, Kominato Y, Takizawa H, Tabata S, Michino J, Nishino K, Yasumura S, Yamamoto F. Transcription starting from an alternative promoter leads to the expression of the human ABO histo-blood group antigen. Transfusion 2003;43: 656-62.
23. Seltsam A, Das Gupta C, Bade-Doeding C, Blasczyk R. A weak blood group A phenotype caused by a translationinitiator mutation in the ABO gene. Transfusion 2006;46: 434-40.
24. Howard MT, Malik N, Anderson CB, Voskuil JL, Atkins JF, Gibbons RJ. Attenuation of an amino-terminal premature stop codon mutation in the ATRX gene by an alternative mode of translational initiation. J Med Genet 2004;41: 951-6.
25. Gurvich OL, Maiti B, Weiss RB, Aggarwal G, Howard MT, Flanigan KM. DMD exon 1 truncating point mutations: amelioration of phenotype by alternative translation initiation in exon 6. Hum Mutat 2009;30: 633-40.
26. Neu-Yilik G, Amthor B, Gehring NH, Bahri S, Paidassi H, Hentze MW, Kulozik AE. Mechanism of escape from nonsense-mediated mRNA decay of human beta-globin transcripts with nonsense mutations in the first exon. RNA 2011;17: 843-54.
27. Anstee DJ. The relationship between blood groups and disease. Blood 2010;115: 4635-43.